Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Open in API
Filings indexed 352 across all filing types
Latest filing 2021-03-31 Annual Report
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
[기재정정]사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2020, filed by Telcon RF Pharmaceutical. It contains detailed company information, history, management, and financial structure. In the context of Korean regulatory filings (DART), a 'Business Report' is the equivalent of an Annual Report (10-K). FY 2020
2021-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the voting outcomes for various agenda items (financial statement approval, director/auditor compensation, etc.) from the meeting held on 2021-03-30. This falls directly under the definition of a Declaration of Voting Results.
2021-03-30 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by 텔콘RF제약. It contains the auditor's opinion (적정 - unqualified), financial statements (assets, liabilities, equity, profit/loss), and details regarding the audit process. While it provides financial data, it is a specific regulatory filing regarding the completion and submission of the audit report, which falls under the 'Audit Report / Information' category. FY 2020
2021-03-22 Korean
사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report) for the fiscal year 2020 (Jan 1, 2020 to Dec 31, 2020) for Telcon RF Pharmaceutical. It contains comprehensive financial data, management discussion, business overview, capital structure, and governance information, which corresponds to the standard format of an annual report (10-K equivalent in the Korean market). FY 2020
2021-03-22 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Telcon RF Pharmaceutical. It outlines the date, location, and agenda items (such as financial statement approval, board remuneration, and articles of incorporation changes). This document serves as the official proxy solicitation and meeting notice provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon, which fits the definition of Proxy Solicitation & Information Statement (PSI).
2021-03-02 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Telcon RF Pharmaceutical. It contains the meeting agenda, voting procedures, electronic voting instructions, and management reference materials (such as director activity reports and major shareholder transaction details). This document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and solicit their votes, which falls under the Proxy Solicitation & Information Statement category.
2021-03-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.